MTOR and glioblastoma: Nowadays a number of clinical trials are ongoing to evaluate the effects of mTOR inhibition with rapamycin (or rapalogs) based on the exciting results obtained both in vitro in glioblastoma cell lines and in preclinical in vivo models of GBM.